1-9 of 9
Stephen P. Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CMV~IMPACT: Results of a Randomized Controlled Trial of Immuno-Prophylactic Adoptive Cellular Therapy following Sibling Donor Allogeneic HSCT

Karl S Peggs, Eleni Tholouli, Ronjon Chakraverty, PhD, Emmanouil Nikolousis, PhD, Adrian Bloor, PhD FRCPath, Stephen Devereux, MD PhD FRCPath, Kim H. Orchard, PhD, Charles Crawley, Anne Parker, Stephen P Robinson, PhD, Frederick Chen, MDPhD, Gordon Cook, MD, Richard E Clark, MBBS MD, Kirsty Thomson, Matthew Cobb, Katy Newton, PhD, Simon Thomas, PhD, Paul Moss, PhD
Journal: Blood
Blood (2014) 124 (21): 1109.
https://doi.org/10.1182/blood.V124.21.1109.1109
Published: 2014
Journal Articles

Pretransplant Characteristics Could Predict Full Donor Chimerism on Day +90 and Day +180 and Outcomes in Reduced Intensity Alemtuzumab Conditioning Allogeneic Transplantation Can Be Influenced by Chimeric Status

Emmanouil Nikolousis, Charles F. Craddock, BM, MRCP, MRCPath, Shankaranarayana Paneesha, MD, Sudhir Tauro, Prem Mahendra, II, Mark Cook, Fiona Clark, Richard Lovell, Sridhar Chaganti, Donald Milligan, MD, MBChB, Dominique Mcmullan, Mike Griffiths, Stephen P Robinson, MD
Journal: Blood
Blood (2008) 112 (11): 4409.
https://doi.org/10.1182/blood.V112.11.4409.4409
Published: 2008
Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation for Follicular Lymphoma Results in An Improved Progression Free Survival When Compared to Autologous Stem Cell Transplantation. An Analysis from the Lymphoma Working Party of the EBMT

Stephen P Robinson, Carmen Canals, Didier Blaise, MD, Kirsty Thomson, Robert Foa, Arturo Iriondo Atienza, Jean-Luc Harousseau, Catherine Cordonnier, MD, Gordon Cook, MD, PhD, Jean-Pierre Jouet, MD, Jean-Yves Cahn, MD, PhD, Charles Crawley, Michel Attal, MD, Marek Trneny, MD, PhD, H. Tilly, Anna Sureda, MD
Journal: Blood
Blood (2008) 112 (11): 458.
https://doi.org/10.1182/blood.V112.11.458.458
Published: 2008
Journal Articles

Identification of Prognostic Factors Predicting the Outcome of Reduced Intensity Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma. An Analysis from the Lymphoma Working Party of the EBMT

Stephen P Robinson, Anna Sureda, Carmen Canals, Sr., Jean-Paul Vernant, Noel-Jean Milpied, PhD, Jürgen Finke, Johan Maertens, Jean-Pierre Jouet, MD, Charles F. Craddock, BM, MRCP, MRCPath, Karl S Peggs, MD, Steven Le Gouill, MD, Norbert Schmitz, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 457.
https://doi.org/10.1182/blood.V112.11.457.457
Published: 2008
Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation for Hodgkin’s Disease. Outcome Depends Primarily on Disease Status at the Time of Transplantation.

Stephen P. Robinson, MB BS, PhD, Norbert Schmitz, MD, PhD, Goli Taghipour, Anna Sureda, MD
Journal: Blood
Blood (2004) 104 (11): 2322.
https://doi.org/10.1182/blood.V104.11.2322.2322
Published: 2004
Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma Is Associated with Substantial Late Transplant Related Mortality and a Poor Outcome in Patients with Chemoresistant Disease.

Stephen P. Robinson, MB, BS, PhD, Norbert Schmitz, MD, PhD, Goli Taghipour, Anna Sureda, MD
Journal: Blood
Blood (2004) 104 (11): 2260.
https://doi.org/10.1182/blood.V104.11.2260.2260
Published: 2004
Journal Articles

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Russell J. Garland, PhD, Paraskevi Diamanti, PhD, Samantha E. West, PhD, Ann Green, MSc, David Carrington, PhD, Sarah J. Groves, BSc, Kerri L. Winship, BSc, Stephen P. Robinson, MD, Anthony Oakhill, MD, Jacqueline M. Cornish, MD, Derwood H. Pamphilon, MD, David I. Marks, MD, Nicholas J. Goulden, MD, Allison G. Blair, PhD, Colin G. Steward, MD
Journal: Blood
Blood (2004) 104 (11): 2244.
https://doi.org/10.1182/blood.V104.11.2244.2244
Published: 2004
Journal Articles

Donor lymphocyte infusions after reduced intensity conditioning allogeneic transplantation: what we need to know

David I. Marks, Anne Parker, Stephen P. Robinson
Journal: Blood
Blood (2004) 104 (1): 295–296.
https://doi.org/10.1182/blood-2004-02-0765
Published: 2004
Journal Articles

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

Clinical Trials & Observations
Stephen P. Robinson, Anthony H. Goldstone, Stephen Mackinnon, Angelo Carella, Nigel Russell, Carmen Ruiz de Elvira, Goli Taghipour, Norbert Schmitz
Journal: Blood
Blood (2002) 100 (13): 4310–4316.
https://doi.org/10.1182/blood-2001-11-0107
Published: 2002